Italia markets closed
  • Dow Jones

    35.433,47
    +65,00 (+0,18%)
     
  • Nasdaq

    14.577,75
    +70,86 (+0,49%)
     
  • Nikkei 225

    27.467,23
    -790,02 (-2,80%)
     
  • EUR/USD

    1,1348
    +0,0018 (+0,16%)
     
  • BTC-EUR

    37.121,57
    +308,43 (+0,84%)
     
  • CMC Crypto 200

    1.000,83
    +6,09 (+0,61%)
     
  • HANG SENG

    24.127,85
    +15,07 (+0,06%)
     
  • S&P 500

    4.593,84
    +16,73 (+0,37%)
     

Is Longeveron a Good Biotech Stock to Buy?

·3 minuto per la lettura
Is Longeveron a Good Biotech Stock to Buy?

An American biotechnology company located in Miami of all places has convinced more than a few investors that its cellular therapy candidate can reverse common effects of aging. This November, shares of Longeveron (NASDAQ: LGVN) shot up more than 10-fold. Investors who missed the boat the first time around are wondering if Longeveron the recent slide is an opportunity to buy a potential long-term winner at a relative discount.

Il nostro obiettivo è creare un luogo sicuro e coinvolgente in cui gli utenti possano entrare in contatto per condividere interessi e passioni. Per migliorare l’esperienza della nostra community, sospendiamo temporaneamente i commenti sugli articoli